Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial

Table 1 Demographics of the EASYDia cohort based on pre-specified baseline body mass index and HbA1c stratification

	EASYDia cohort (N = 7170)
Demography
Men^a	2949 (41.5)
Age (years)*	58.9 (10.6)
Baseline body mass index (kg/m²)^b
18.5 to < 25.0	838 (11.9)
25.0 to < 30.0	3029 (42.9)
≥ 30.0	3191 (45.2)
Baseline HbA1c (%)^c
> 7.0 to ≤ 8.0	1765 (17.4)
> 8.0 to ≤ 9.0	2074 (47.1)
> 9.0% to ≤ 10.0	809 (18.4)
> 10.0	758 (17.2)

Data are presented as n (%) or *mean (standard deviation)
^aThe gender of 63 (0.88%) participants were not reported; ^b Data collected from the safety set; ^c Data collected from the full analysis set

ISSN: 1758-5996